CERE-130

N/A

Report date: 2024/12/18 15:18:40

Base Information

Drug NameCERE-130
Drug Alias NameCERE-130
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionInsulin-like growth factor I stimulants
TargetsInsulin-like growth factor I
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCeregene Inc
China Registration ClassN/A

Develop Information

Active CompaniesCeregene Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A